These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


362 related items for PubMed ID: 737252

  • 1. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ, Schildkraut JJ, Schatzberg AF, Herzog JM.
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [Abstract] [Full Text] [Related]

  • 2. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders.
    Schildkraut JJ, Orsulak PJ, Schatzberg AF, Herzog JM.
    Schizophr Bull; 1980 Dec; 6(2):220-5. PubMed ID: 7375853
    [Abstract] [Full Text] [Related]

  • 3. [The preliminary study of monoamine oxidase activity in platelets in patients with schizophrenia and affective disorder].
    Lin Y.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):325-7, 382. PubMed ID: 1304991
    [Abstract] [Full Text] [Related]

  • 4. Delusional misidentification and platelet monoamine oxidase.
    Barton JL, Chaparala S, Barton ES, Jackson IV, Davis LG.
    Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
    [Abstract] [Full Text] [Related]

  • 5. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients.
    Schildkraut JJ, Herzog JM, Orsulak PJ, Edelman SE, Shein HM, Frazier SH.
    Am J Psychiatry; 1976 Apr; 133(4):438-40. PubMed ID: 1267046
    [Abstract] [Full Text] [Related]

  • 6. Platelet monoamine oxidase response to lithium treatment in psychiatric patients.
    Huang LG, Bowden CL.
    J Clin Psychopharmacol; 1984 Dec; 4(6):326-31. PubMed ID: 6512000
    [Abstract] [Full Text] [Related]

  • 7. [Multiple forms of thrombocyte monoamine oxidase in patients with manic-depressive psychosis and recurrent schizophrenia].
    Smirnov AV, Prilipko LL.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988 Dec; 88(4):76-8. PubMed ID: 3414255
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population.
    Demisch L, Gebhart P, Kaczmarczyk P, von der Mühlen H, Bochnik HJ.
    Biol Psychiatry; 1981 Jan; 16(1):21-33. PubMed ID: 7225472
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
    Sullivan JL, Coffey CE, Basuk B, Cavenar JO, Maltbie AA, Zung WW.
    Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
    [Abstract] [Full Text] [Related]

  • 12. Blood platelet monoamine oxidase activity in psychiatric patients.
    Friedman E, Shopsin B, Sathananthan G, Gershon S.
    Am J Psychiatry; 1974 Dec; 131(12):1392-4. PubMed ID: 4432940
    [No Abstract] [Full Text] [Related]

  • 13. Association between high platelet MAO activity and response to MAO inhibitor in depressed bipolars: case reports.
    Rihmer Z, Arató M, Bagdy G.
    Pharmacopsychiatria; 1983 Jul; 16(4):119-20. PubMed ID: 6634937
    [Abstract] [Full Text] [Related]

  • 14. Platelet monoamine oxidase in chronic schizophrenic patients.
    Berger PA, Ginsburg RA, Barchas JD, Murphy DL, Wyatt RJ.
    Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
    [Abstract] [Full Text] [Related]

  • 15. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE, Wise CD, Potkin SG, Zalcman S, Phelps BH, Lovenberg W, Wyatt RJ.
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [Abstract] [Full Text] [Related]

  • 16. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B, Kosower N, Zipser Y, Shreiber-Schul N, Apter A, Tyano S, Weizman A.
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [Abstract] [Full Text] [Related]

  • 17. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia.
    Wyatt RJ, Murphy DL.
    Res Publ Assoc Res Nerv Ment Dis; 1975 Feb; 54():289-97. PubMed ID: 769116
    [No Abstract] [Full Text] [Related]

  • 18. Relationship of auditory hallucinations and paranoia to platelet MAO activity in schizophrenics: sex and race interactions.
    Meltzer HY, Zureick JL.
    Psychiatry Res; 1987 Oct; 22(2):99-109. PubMed ID: 3685225
    [Abstract] [Full Text] [Related]

  • 19. Are paranoid schizophrenics biologically different from other schizophrenics?
    Potkin SG, Cannon HE, Murphy DL, Wyatt RJ.
    N Engl J Med; 1978 Jan 12; 298(2):61-6. PubMed ID: 619236
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.